[][com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75811]], camposKey:2045-2322 2022-12-01 Impact of intra-abdominal pressure on early kidney transplant outcomes00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75902]], camposKey:0902-0063 2022-03-01 Bioavailability of once-daily tacrolimus formulations used in clinical practice in the management of De Novo kidney transplant recipients: the better study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61598]], camposKey:2045-2322 2020-01-01 Validation of a survival benefit estimator tool in a cohort of European kidney transplant recipients00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61621]], camposKey:2077-0383 2019-01-01 Impact on outcomes across KDIGO-2012 AKI criteria according to baseline renal function00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=17252]], camposKey:1886-2845 2017-01-01 Correlaciones clínicas de los recuentos en sangre periférica de células T reguladoras en el post-trasplante renal8291, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=23321]], camposKey:1886-2845 2017-01-01 Evolución del metabolismo óseo-mineral y de la lesión vascular y ósea tras el trasplante renal6467, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61599]], camposKey:1932-6203 2017-01-01 Hypoglycemia following intravenous insulin plus glucose for hyperkalemia in patients with impaired renal function00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58798]], camposKey:0025-7753 2017-01-01 Peripheral blood regulatory T cell counts as a predictive biomarker for the outcome of kidney transplant: A systematic review523535, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=23320]], camposKey:1886-2845 2017-01-01 ¿Son los recuentos de células T reguladoras en sangre periférica un biomarcador predictivo y pronóstico para mejorar los resultados en el trasplante renal? Una revisión sistemática4056, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61587]], camposKey:0041-1345 2016-01-01 Implementation of a National Priority Allocation System for Hypersensitized Patients in Spain, Based on Virtual Crossmatch: Initial Results28712875, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=24717]], camposKey:0211-6995 2016-01-01 Leucoencefalopatía posterior reversible: un caso recurrente y atípico en hemodiálisis192193, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61588]], camposKey:0934-0874 2015-01-01 Cytomegalovirus prevention strategies in seropositive kidney transplant recipients: An insight into current clinical practice10421054, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=23319]], camposKey:1886-2845 2015-01-01 Impacto del riesgo cardiovascular del donante-receptor en la supervivencia del injerto y receptor de trasplante renal cadáver. ¿De dónde venimos?, ¿hacia dónde vamos?5555, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43883]], camposKey:1886-2845 2015-01-01 Mejoría espontánea de estenosis de arteria renal en paciente trasplantada renal5758, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43884]], camposKey:0210-6523 2011-01-01 Trasplante renal en el Hospital Clínico de Valladolid6573, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61589]], camposKey:1753-0784 2010-01-01 Heterogeneity of induction therapy in Spain: Changing patterns according to year, centre, indications and results00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61590]], camposKey:0902-0063 2009-01-01 A randomized trial of basiliximab with three different patterns of cyclosporin A initiation in renal transplant from expanded criteria donors and at high risk of delayed graft function2332, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61591]], camposKey:0902-0063 2006-01-01 Increased cardiovascular risk profile and mortality in kidney allograft recipients with post-transplant diabetes mellitus in Spain650658, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61593]], camposKey:0041-1345 2005-01-01 Cystatin C as a marker of renal function in kidney transplant patients38443847, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61592]], camposKey:0041-1345 2005-01-01 Detection and treatment of post kidney transplant hyperglycemia: A spanish multicenter cross-sectional study38133816, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61594]], camposKey:0931-0509 2004-01-01 Recipient age as a determinant factor of patient and graft survival00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61595]], camposKey:0041-1345 2003-01-01 Tacrolimus-basiliximab versus cyclosporine-basiliximab in renal transplantation "de novo": Acute rejection and complications16941696, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42127]], camposKey:0886-022X 2002-01-01 Antioxidant enzyme determination and a study of lipid peroxidation in renal transplantation353359, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42126]], camposKey:0886-022X 2002-01-01 Glutathione determination and a study of the activity of glutathione-peroxidase, glutathione-transferase, and glutathione-reductase in renal transplants421432, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30559]], camposKey:0895-7061 2000-01-01 The use of antihypertensive therapy in Spain (1986-1994)607610, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61586]], camposKey:0085-2538 1999-01-01 Does the dialysis modality modify the oxidative stress in patients on dialysis?360360, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61596]], camposKey:0212-7199 1995-01-01 Nephrotoxicity of acyclovir Nefrotoxicidad por aciclovir501502, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61597]], camposKey:0211-6995 1988-01-01 Role of platelet activating factor (PAF) antagonists in a rat model of cyclosporine nephrotoxicity3037][][][][][][][][][][][][][][][][][][][][][][com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63ebc0, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63ec6d, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e51a, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e9a9, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63d6eb, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e5a8, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63dbdc, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e445, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e444, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63d6f7][][][][][][][][com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@45f43b]][][][][][][][]